COVID19

Planning To Get Booster Shot? Here’s How Much You Will Have To Pay For Serum Institute’s Covishield

SII CEO Adar Poonawalla also welcomed the government’s move to allow precaution dose of the vaccine to all aged above 18 years at private vaccination centres, saying it will further provide long-term protection against the virus, and aid ease of travel.

View Post

Tamil Nadu Ramps Up Airport Surveillance Amid Global COVID-19 Worries

At the airports, he said fever screening camps are conducted regularly and Health department officials continue to do two per cent random sampling of passengers who arrive from various countries.

View Post

COVID-19: Face Masks No More Mandatory In Delhi, Maharashtra

DDMA has decided that there will be no fine for not wearing face masks at public places.

In Maharashtra, the state government announced that all Covid-related curbs, including the wearing of masks, would be lifted from April 2.

View Post

COVID-19: Variant Much Worse Than Omicron Likely In Next Two Years, Says UK Epidemiologist

Omicron evolved from a different part of the virus’s lineage, and there is no guarantee the next strain will evolve directly from Omicron.

UK’s SAGE advisors have warned of a “realistic possibility” that a more lethal variant could emerge that kills one in three people, in line with earlier coronaviruses such as MERS.

View Post

World Tuberculosis Day: Association Between Tuberculosis And COVID‐19 Severity And Mortality

Covid-19 and tuberculosis (TB) have striking similarities. They are airborne infections that are easily transmitted. Both are more likely to spread in crowded environments and to harm people who have…

View Post

COVID-19: NTAGI Reduces Gap Between Two Doses Of Covishield, Check Details

Second dose of COVID-19 vaccine Covishield is currently given between 12-16 weeks.

The decision will lead to accelerated administration of the second dose of Covishield to the remaining six to seven crore individuals amid rising cases in several countries.

View Post

COVID19: Vaccination For Children In 12-14 Years Group To Begin Tomorrow

Biological E’s Corbevax will be administered to 12-14 years age-group.

The National Technical Advisory Group on Immunization (NTAGI) is learnt to have given its recommendation to begin vaccination of children in the 12-15 years age group.

View Post

Menu

COVID19

Planning To Get Booster Shot? Here’s How Much You Will Have To Pay For Serum Institute’s Covishield

Tamil Nadu Ramps Up Airport Surveillance Amid Global COVID-19 Worries

COVID-19: Face Masks No More Mandatory In Delhi, Maharashtra

COVID-19: Variant Much Worse Than Omicron Likely In Next Two Years, Says UK Epidemiologist

World Tuberculosis Day: Association Between Tuberculosis And COVID‐19 Severity And Mortality

COVID-19: NTAGI Reduces Gap Between Two Doses Of Covishield, Check Details

COVID19: Vaccination For Children In 12-14 Years Group To Begin Tomorrow

Methanol Poisoning: All You Need to Know About The Silent Killer Lurking in Alcoholic Drinks

Winter Heart Attack Alert: 8 Doctor-Approved Lifestyle Changes for Better Cardiovascular Health

Sea Level Set to Rise 1 Metre by 2100, Threatening 14 Million in Coastal Regions: Study Warns

Not Just Smog, Surge in ‘Walking Pneumonia’ Cases Alarms Delhi Residents

Man Declared Dead In Rajasthan Hospital Found Alive Before Last Rites; 4 Doctors Suspended

Breathlessness and Persistent Coughing: Early Signs of a Progressive Lung Disease, Experts Warn

Walking Pneumonia Symptoms: The Silent Respiratory Illness You Could Be Overlooking

Diabetes Treatment Breakthrough: Canagliflozin Improves Kidney Oxygenation, Shows Study